VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,737,000 | +25.1% | 117,664 | -14.4% | 0.01% | +40.0% |
| Q1 2018 | $2,187,000 | -26.5% | 137,464 | -3.4% | 0.01% | -37.5% |
| Q4 2017 | $2,975,000 | +77.3% | 142,264 | +21.2% | 0.01% | +60.0% |
| Q3 2017 | $1,678,000 | +21.0% | 117,400 | +2.8% | 0.01% | +25.0% |
| Q2 2017 | $1,387,000 | +10.3% | 114,200 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,258,000 | -22.2% | 114,200 | +2.6% | 0.00% | -33.3% |
| Q4 2016 | $1,616,000 | -41.9% | 111,300 | -2.0% | 0.01% | -40.0% |
| Q3 2016 | $2,782,000 | -16.7% | 113,600 | -2.7% | 0.01% | -23.1% |
| Q2 2016 | $3,341,000 | -71.7% | 116,800 | -31.7% | 0.01% | -75.0% |
| Q1 2016 | $11,823,000 | -38.7% | 170,938 | -10.3% | 0.05% | -36.6% |
| Q4 2015 | $19,302,000 | -59.5% | 190,571 | -28.8% | 0.08% | -61.0% |
| Q3 2015 | $47,615,000 | -36.4% | 267,660 | -7.8% | 0.21% | -31.4% |
| Q2 2015 | $74,824,000 | +14.9% | 290,387 | -3.5% | 0.31% | +12.9% |
| Q1 2015 | $65,119,000 | +133.6% | 301,011 | +55.0% | 0.27% | +116.8% |
| Q4 2014 | $27,879,000 | +59.9% | 194,142 | +46.2% | 0.12% | +48.8% |
| Q3 2014 | $17,438,000 | +2.5% | 132,800 | -1.1% | 0.08% | +3.7% |
| Q2 2014 | $17,011,000 | -2.4% | 134,300 | +1.6% | 0.08% | -6.9% |
| Q1 2014 | $17,421,000 | +11.8% | 132,200 | -0.5% | 0.09% | +8.8% |
| Q4 2013 | $15,576,000 | +15.2% | 132,800 | +2.6% | 0.08% | +5.3% |
| Q3 2013 | $13,520,000 | +23.8% | 129,400 | +1.9% | 0.08% | +22.6% |
| Q2 2013 | $10,917,000 | – | 127,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |